Researchers at the University of Toronto see a future where a single injection under the eyelid could replace months of daily ...
The US Food and Drug Administration has approved mirdametinib for the treatment of neurofibromatosis type 1 (NF1) in adults ...
Dravet syndrome and other developmental epileptic encephalopathies are rare but devastating conditions that cause a host of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback